Construction And Real Estate Tenders

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the Active Ingredient Beclometasone Formoterol (Dos)

Oh-Biologika-2023-10 Agalsidase Alfa

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the Active Ingredient Beclometasone Formoterol (Ihp and Inh)

Conclusion of Non-Exclusive Discount Agreements According to § 130A Paragraph 8 Sgb V for the Active Ingredient Beclometasone/Formoterol/Glycopyrronium

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Olanzapine Atc Code: N05ah03 for the Period from July 1St, 2023 to June 30Th, 2025

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Cicosplorin Atc Code: S01xa18 for the Period from July 1St, 2023 to June 30Th, 2025

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Perindopril Erbumin, Amlodipine Besilate, Atc Code: C09bb04 for the Period from 07/01/2023 to 06/30/2025

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Dexamethasone, Gentamicin, Atc Code: S01ca01 for the Period from July 1St, 2023 to June 30Th, 2025